source
- ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionAt a big meeting for weight loss drugs, Lilly’s “triple G” therapy set a new standard as lingering doubts surrounded other competing treatments.BioPharma Dive · 1mo ago↗ source
- Innovation alone is no longer enough in biopharmaIn biopharma, the next edge may come from the systems that turn discovery into scale.BioPharma Dive · 1mo ago↗ source
- Precision under pressure: Logistic solutions for nuclear medicine scalabilityRacing the clock: How precision logistics deliver life-saving nuclear medicine.BioPharma Dive · 1mo ago↗ source